IPP Bureau
FDA grants breakthrough status to Laguna's mRNA blood test for schizophrenia diagnosis
By IPP Bureau - May 02, 2026
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win
By IPP Bureau - May 02, 2026
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
Bayer pushes stroke prevention drug forward in China as regulators accept key filing
By IPP Bureau - May 02, 2026
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
IMCD posts steady Q1 2026 performance with €130 million EBITA amid global uncertainty
By IPP Bureau - May 02, 2026
The company posted revenue of €1,267 million, up 6% on a constant currency basis
Gilead completes $7.8B Arcellx acquisition & takes full control of Myeloma CAR-T candidate
By IPP Bureau - May 02, 2026
Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right
Thermo Fisher opens flagship US Bioprocess Design Center in Massachusetts
By IPP Bureau - May 02, 2026
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
Pawan Varshney elevated to Director of Finance – South Asia at Cepheid
By IPP Bureau - May 01, 2026
His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia
Nitin Wadhwa joins Sebia as General Manager to lead India growth
By IPP Bureau - May 01, 2026
Wadhwa brings over two decades of experience driving growth, transformation, and customer-centric strategies in the medical devices and diagnostics sector
PFCD panel flags insurance gaps limiting access to robotic joint replacement in India
By IPP Bureau - May 01, 2026
Leading orthopaedic experts call for equitable insurance coverage to patients for accessing advanced, precision-driven joint replacement technologies
Microbot Medical Inc. appoints Alon Tamir as VP Sales EMEA
By IPP Bureau - May 01, 2026
Tamir brings more than 20 years of experience in the medical technology sector
Aakash Healthcare publishes landmark study on integrated emergency clinical codes
By IPP Bureau - May 01, 2026
Study introduces structured, condition-specific emergency coding system to improve coordination, response time, and patient safety in tertiary care hospitals
ARTEMIS study shows significant gains in adolescent mental health across urban slums in India
By IPP Bureau - May 01, 2026
The George Institute India’s large-scale community-based model demonstrates reduced depression, self-harm, and suicide risk among adolescents in Delhi and Vijayawada
Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO
By IPP Bureau - May 01, 2026
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Fortis Cancer Summit 2026 to unite global oncology leaders in New Delhi
By IPP Bureau - May 01, 2026
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
Livasa Hospitals appoints Kamal Kant Gambhir as Chief Financial Officer
By IPP Bureau - May 01, 2026
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
